05/23/2024

Scientists Are Studying Weight-loss Drugs for More Than Weight Loss

The list includes diabetes, heart disease and even more

The new weight-loss drugs Wegovy and Zepbound are in high demand, and the clamoring will only increase in coming years, experts predict. That's because drugs like these, which rely at least in part on the appetite-regulating hormone GLP-1, are being investigated not just for weight loss and diabetes, but also for a wide range of other conditions.

"Weight loss is only part of it," said Dr. Ian Neeland, chair of the American Heart Association’s obesity science committee and an associate professor of medicine at Case Western Reserve University.

Here's the latest (and still-growing) list.

Please select this link to read the complete article from TIME.